0
Applied AI·October 27, 2026·1 min read

Anthropic Says It Will Revolutionize Biology—Some Day

Share

Anthropic’s IPO filing tempering its own “revolutionize biology” narrative is a useful calibration—labs are starting to separate long-horizon scientific upside from near-term commercial reality under SEC scrutiny. If you’re in bio or pharma, treat current foundation models as accelerants for specific tasks, not turnkey discovery engines.